Home Blood Pressure and Telemedicine: A Modern Approach for Managing Hypertension During and After COVID-19 Pandemic

被引:0
作者
Barbara Citoni
Ilaria Figliuzzi
Vivianne Presta
Massimo Volpe
Giuliano Tocci
机构
[1] University of Rome “Sapienza”,Hypertension Unit, Division of Cardiology, Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology
[2] Sant’Andrea Hospital,undefined
来源
High Blood Pressure & Cardiovascular Prevention | 2022年 / 29卷
关键词
Hypertension; Blood pressure; Telemedicine; Telemonitoring; Home blood pressure monitoring; COVID-19;
D O I
暂无
中图分类号
学科分类号
摘要
Hypertension is the most common cardiovascular risk factor for acute cardiovascular outcomes, including acute coronary disease, stroke, chronic kidney disease and congestive heart failure. Despite the fact that it represents the most prevalent risk factor in the general population, mostly in elderly individuals, its awareness is still relatively low, being about one third of patients living with undiagnosed hypertension and high risk of experiencing acute cardiovascular events. In addition, though recent improvement in pharmacological and non-pharmacological therapeutic options, hypertension is largely uncontrolled, with about 35–40% of treated hypertensive patients achieving the recommended therapeutic targets. Among different modern interventions proposed for improving blood pressure control in treated hypertensive patients, a systematic adoption of home BP monitoring has demonstrated to be one of the most effective. Indeed, it improves patients’ awareness of the disease and adherence to prescribed medications and allows tailoring and personalizing BP lowering therapies. Home BP monitoring is particularly suitable for telemedicine and mobile-health solutions. Indeed, in specific conditions, when face-to-face interactions between patients and physicians are not allowed or even suspended, as in case of COVID-19 pandemic, telemedicine may ensure effective management of hypertension, as well as other cardiovascular and non-cardiovascular comorbidities. This review will summarize strengths and limitations of telemedicine in the clinical management of hypertension with a particular focus on the lessons learned during the COVID-19 pandemic.
引用
收藏
页码:1 / 14
页数:13
相关论文
共 351 条
  • [1] Roth GA(2020)Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study J Am Coll Cardiol 76 2982-3021
  • [2] Mensah GA(2005)Global burden of hypertension: analysis of worldwide data Lancet 365 217-223
  • [3] Johnson CO(2017)Prevalence and control of hypertension in the general practice in Italy: updated analysis of a large database J Hum Hypertens 31 258-262
  • [4] Addolorato G(2015)Blood pressure levels and control in Italy: comprehensive analysis of clinical data from 2000–2005 and 2005–2011 hypertension surveys J Hum Hypertens 29 696-701
  • [5] Ammirati E(2020)Blood Pressure Targets Achievement According to 2018 ESC/ESH Guidelines in Three European Excellence Centers for Hypertension High Blood Press Cardiovasc Prev. 27 51-59
  • [6] Baddour LM(2020)Blood pressure target achievement under monotheraphy: a real-life appraisal High Blood Press Cardiovasc Prev. 27 587-596
  • [7] Kearney PM(2004)Blood pressure control according to new guidelines targets in low- to high-risk hypertensives managed in specialist practice J Hypertens 22 2387-2396
  • [8] Whelton M(2016)Why in 2016 are patients with hypertension not 100% controlled? A call to action. J Hypertens. 34 1480-1488
  • [9] Reynolds K(2018)2018 ESC/ESH Guidelines for the management of arterial hypertension Eur Heart J 39 3021-3104
  • [10] Muntner P(2013)2012 consensus document of the Italian Society of Hypertension (SIIA): strategies to improve blood pressure control in Italy: from global cardiovascular risk stratification to combination therapy High Blood Press Cardiovasc Prev. 20 45-52